Altasciences acquires California-based CRO WCCT Global

TAGS

Altasciences has acquired WCCT Global, an early stage clinical research organization (CRO) based in Southern California, for an undisclosed price.

The Canada-based mid-size CRO/CDMO said that the acquisition will complement its existing clinical operations in Montreal and Kansas City, while being in close proximity to its preclinical facility in Washington State.

See also  Caesars to acquire betting and gambling company William Hill

Steve Mason – Co-Chief Operating Officer at Altasciences said: “This acquisition expands Altasciences’ footprint by providing Phase I and II clinical pharmacology services on the West Coast, and adds 180 beds to our current 400-bed offering. Furthermore, it allows us to enhance our capabilities with expertise in ethnobridging and other specialty areas for hard-to-recruit study populations.”

Altasciences acquires California-based CRO WCCT Global

Altasciences acquires California-based CRO WCCT Global. Photo courtesy of Adam Radosavljevic from Pixabay.

Established in 1998, WCCT Global is said to have carried out more than 600 Phase I studies.

See also  Model Medicines, Sanford Burnham Prebys forge AI-driven drug discovery partnership

Gregory Hanson – Executive Chairman of WCCT Global said: “Joining the Altasciences team will enhance our offering while allowing us to continue the responsive delivery of quality research data to our global biopharmaceutical clients.”

CATEGORIES
TAGS
Share This